Prediabetes syndrome – Talk Bio

Actionable Insights Powered by AI

Viking Therapeutics to Highlight VK2735 Clinical Data at ObesityWeek 2025

1 month ago talkbio0Tagged Clinical Data, Clinical Trials, GLP-1/GIP Dual Agonist, Metabolic Syndrome X, Obesity, ObesityWeek 2025, Prediabetes syndrome, VANQUISH-1, venture, Viking Therapeutics, VK2735

Viking Therapeutics; VK2735; ObesityWeek 2025; VENTURE trial; VANQUISH-1 trial; GLP-1/GIP dual agonist; clinical data; obesity; prediabetes; metabolic syndrome

Lilly’s Tirzepatide Demonstrates Significant Reduction in Diabetes Risk and Sustained Weight Loss in Overweight Adults

1 year ago talkbio0Tagged Adult, Diabetes, Eli, Eli Lilly, Mounjaro, Obesity, Overweight, Prediabetes syndrome, Risk Reduction, Sustained, Weight Loss, Zepbound

tirzepatide, diabetes risk reduction, sustained weight loss, overweight adults, pre-diabetes, obesity, Eli Lilly, Mounjaro, Zepbound